<Insert Picture Here>
Healthcare and Life Sciences Mission & Strategy
Leo LiangVice PresidentHSGBU Japan and APAC
The following is intended to outline our general product direction. It is intended for information
purposes only, and may not be incorporated into any contract. It is not a commitment to deliver any
material, code, or functionality, and should not be relied upon in making purchasing decisions.The development, release, and timing of any
features or functionality described for Oracle’s products remains at the sole discretion of Oracle.
Oracle Corporation
• World’s largest enterprise software vendor
• Four product families• Applications, Database, Middleware, and
Infrastructure
• $22.4 billion revenue, FY08
• 325,000 global customers
• 85,000 employees
• Operating in 145 countries
Oracle’s Leadership in Health Sciences
Use Oracle Applications to RunTheir Business
Use Oracle Applications to RunTheir Business
Use Oracle Applications to RunTheir Business
Use Oracle Applications to RunTheir Business
Use Oracle Applications to RunTheir Business
20 of the Top 20 Pharmaceutical Companies
8 of the Top 10 Contract Research Organizations
9 of the Top 10 Medical Device Companies
10 of the Top 10 Research Universities
10 of the Top 10 Healthcare Organizations
Total RecallSOA Suite
Audit VaultApps Integration Arch
Business Process Mgmt Self-Managing Database Grid ComputingOracle Data Guard
Real Application ClustersFirst Comprehensive
CRM SuiteFlashback Query
First Internet ApplicationsBuilt-in Java VM
Partitioning SupportFull Applications
Implementation MethodologyIndustry-Specific Business Applications
Object Relational SupportMultimedia Support
Data Warehousing OptimizationsFirst Unix-Based Applications
Parallel OperationDistributed SQL & Transaction SupportCluster & MPP Support
Total RecallSOA Suite
Audit VaultApps Integration Arch
Business Process Mgmt Self-Managing Database Grid ComputingOracle Data Guard
Real Application ClustersFirst Comprehensive
CRM SuiteFlashback Query
First Internet ApplicationsBuilt-in Java VM
Partitioning SupportFull Applications
Implementation MethodologyIndustry-Specific Business Applications
Object Relational SupportMultimedia Support
Data Warehousing OptimizationsFirst Unix-Based Applications
Parallel OperationDistributed SQL & Transaction SupportCluster & MPP Support
Multi-Version Read ConsistencyClient/Server Support
Platform PortabilityCommercial SQL Implementation
• 1,500 Patents• 1,500 Patents in Progress
1970’s… 2000…1980’s… 1990’s…
30 Years of R&D Innovation
$1.3 $1.5$1.9
$2.2
R&D Spending, $B20% CAGR $2.7
FY08FY04 FY05 FY06 FY07
Growth Through AcquisitionCreating Best-in-Business Capabilities
Oracle FY 2005 Oracle FY 2006 Oracle FY 2007 Oracle FY 2008
4 Acquisitions 17 Acquisitions 14 Acquisitions 8 Acquisitions
More Value Less Complexity
More Flexibility Less Cost
More Choice Less Risk
Comprehensive Industry Portfolio
Standards-Based Architecture
Designed toWork Together
Complete Open Integrated
Oracle’s Application Strategy
HSGBU Mission
Our Missionis to be the leading strategic supplier of software solutions to
pharmaceutical, biotech, medical device, and healthcare companies.
discover, develop, and successfully market innovativeproducts and services to:
We will help them
• prevent and cure disease
• enhance quality of life
• and meet their shareholder and stakeholder expectations.
HSGBU Strategy
Our Strategyis to grow to #1 market share for Health Sciences applications
among the largest and/or fastest growing pharmaceutical, biotech,
medical device, and integrated delivery networks worldwide by
offering an integrated application suite sold and supported through
a global ecosystem that provides customers with the industry’s
highest return on investment and best ownership experience.
“Accelerating Insights for Better Health”
Oracle Life Sciences FootprintComplete. Open. Integrated.
CRM & Marketing
Sales Order Mgmt Field Service Samples MgmtCall CenterLoyaltyMarketing
Analytics Business Operations
Clinical Analytics
Operational Analytics
Scientific Analytics
Statistical Analysis
Clinical Development
Data Integration
EDC
Safety
IVRSAMC-Driven Trials
ePROTrial Operations
Trial Design/Setup
Modeling/Simulation
Bio-Specimen MgmtPharmacovigilance
Lab Info Mgmt (LIMS)
Pre-Clinical/Discovery
Clinical Mfg
Pre-Clinical Dev
Scientific Cont. Mgmt
ManufacturingData Mgmt/Collaboration Supply Chain
Image Management
Terminology Services
Clinical Data Mgmt Content Mgmt & Regulatory Submission
Research Collaboration/Grids
Clinical Portfolio Mgmt ePedigree
Supply Chain Planning
Warehouse Management
PLM Sourcing
ERP
Process Operations
Discrete Mfg
Process Mfg
Corporate Administration
Infrastructure
Integration & Collaboration Enterprise Infrastructure
Compensation Facilities Contracts Procurement HR Help DeskFinancialsEPM IT Help DeskHuman Resources
Oracle Partner
The Growing Industry Interdependence Between Healthcare and Life Sciences
Personalized medicineBio-marker discovery
Safety and PharmacovigilanceSubmissions
Pharma/Biotech
Adaptive Clinical Trials
ResearchNetworks
Healthcare Institutions
ClinicalResearch
Labs & Biobanks
CareDelivery
Submission
Enabling Personalized MedicineLinking Biomedical Research to Healthcare
Innovation
Operations
EDC
Imaging
Safety
Clinical Mfg
CTMS
Laboratory
LIFE SCIENCES SOLUTION INTEGRATED SUITE
Pharmacovigilance
Scientific Analytics
Operational Analytics
Simulation & Modeling
Portfolio Analysis
DataManagement
Study Design
ClinicalTrial Sites
Labs &Biobanks
Pharma/Biotech
CRO
Scientific Inference
Oracle’s Current Clinical Development and Safety Applications
Clinical Trial Management(Siebel Clinical)
Electronic Data Capture(Oracle Remote Data Capture)
Clinical Data Management System
(Oracle Clinical)
PharmacovigilanceReporting & Call Center
(Oracle Adverse Event Reporting System)
Term Classification/Dictionary Management(Oracle Thesaurus Management System)
Clinical Integration, Warehousing, & Reporting(Oracle Life Sciences Data Hub)
China will be Top 5 in Pharmaceutical Market by 2010
USA 91
Japan 52
Germany 20
France 18
Italy 10
Brazil 8.4
UK 8.2
Spain 6.0
South Korea 4.5
Canada 4.3
China 4.3
USA 150
Japan 58
Germany 17
France 17
UK 11
Italy 11
China 6.8
Brazil 6.7
Canada 6.3
Spain 6.2
USA 262
Japan 65
Germany 24
France 21
UK 16
Italy 15
China 13
Brazil 10
Canada 10
Spain 9.8
USA 466
Japan 81
Germany 37
France 28
China 25
UK 24
Italy 23
Canada 17
Spain 16
Brazil 15
1996 2000 2005 2010E
Top
10
Pharmaceutical market size (US$B)Source: The Boston Consulting Group
China’s Changing Pharmaceutical Market Profile
Source: International Federation of Pharmaceutical Manufacturers Association
Patented21%
Branded Generics
19%Generics
37%
OTC23%
OTC15%
Generics62%
Branded Generics
14%
Patented9%
+8%+12%+4%
-25%
Chinese pharmaceuticals market profile 2000 Chinese pharmaceuticals market profile 2010 forecast
China Pharmaceutical Market
•Double digits GDP growth during the past decade year after year
•Generic drug market share will drop 25% in 10 years from 2000 to 2010
•Patented drug market share will grow from 9% to 21% from 2000 to 2010
•Huge patient pool, ~250M
•Strategic, supportive government policies and investments
China healthcare market kept a constant growth and a continuous demand for new medicinal products.
Health Sciences Global Management TeamNeil de Crescenzo
GM
Mike McCannN. America LS Sales
Jonathan BestEMEA Sales
Leo LiangAPAC Sales
Kris JoshiStrategy & Business Dev
Ramlal WaghrayDevelopment
Greg JonesArchitecture
Nick GiannasiLS Product Strategy
Penny LieHC Product Strategy
Michele BecciStrategic Accounts
Mark McCourtN. America HC Sales
Dave BunkerAlliances
Sales, Consulting, and Marketing
Product Management
Business Operations
Patrick KesselringSales Operations
Chris IbellGlobal Consulting
Sean FordGlobal Marketing
Thank you!A Win / Win for You and Us.
Thank you!
A Win / Win for You and Us.
Oracle’s HSGBU Clinical Development and Safety Strategy
Expand sales, marketing, partner, and consulting infrastructureNew license and deployment models
Go-to-Market Excellence
Current Applications
NO COMMON PLATFORMNO COMMON PLATFORM
FEATURE SET FOR SINGULAR FEATURE SET FOR SINGULAR BUSINESS PROCESSESBUSINESS PROCESSES
AIA & Composite Applications
ANALYTICSANALYTICS
COMPOSITE APPLICATIONSCOMPOSITE APPLICATIONSUSING AIA: STUDY DESIGN, USING AIA: STUDY DESIGN,
INVESTIGATOR PORTALINVESTIGATOR PORTAL
Next-Generation Integrated Suite (HSS)
NEW INTEGRATED SUITENEW INTEGRATED SUITE
INTEGRATION PLUS NEWINTEGRATION PLUS NEWFEATURES FOR ENDFEATURES FOR END--TOTO--ENDEND
BUSINESS PROCESSESBUSINESS PROCESSES